2-Arachidonoylglycerol enhances the phagocytosis of opsonized zymosan by HL-60 cells differentiated into macrophage-like cells

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 7, 2007, Pages 1199-1205

  Gokoh, Maiko ^a   Kishimoto, Seishi ^a   Oka, Saori ^a   Sugiura, Takayuki ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

2 Arachidonoylglycerol; Anandamide; Cannabinoid; Macrophage; Phagocytosis

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID 2 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE; WORTMANNIN; ZYMOSAN;

ARTICLE; CELL DIFFERENTIATION; CELL STIMULATION; CELL STRAIN HL 60; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY CELL; MACROPHAGE; MICROORGANISM; MONOCYTE; OPSONIZATION; PHAGOCYTOSIS;

ANDROSTADIENES; ANTIGENS, CD18; ARACHIDONIC ACIDS; BORNANES; CELL DIFFERENTIATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLYCERIDES; HL-60 CELLS; HUMANS; MACROPHAGES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERTUSSIS TOXIN; PHAGOCYTOSIS; PYRAZOLES; ZYMOSAN;

EID: 34447129568     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.1199     Document Type: Article

References (56)

1. Matsuda L. A., Lolait S. J., Brownstein M. J., Young A. C., Bonner T. I., Nature (London), 346, 561-564 (1990).
2. Herkenham M., "Cannabinoid Receptors," ed. by Pertwee R. G., Academic Press, London, 1995, pp. 145-166.
3. Munro S., Thomas K. L., Abu-Shaar M., Nature (London), 365, 61-65 (1993).
4. Di Marzo V., Melck D., Bisogno T., De Petrocellis L., Trends Neurosci., 21, 521-528 (1998). Erratum Trends Neurosci., 22, 80 (1999).
5. Schlicker E., Kathmann M., Trends Pharmacol. Sci., 22, 565-572 (2001).
6. Devane W. A., Hanus L., Breuer A., Pertwee R. G., Stevenson L. A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R., Science, 258, 1946-1949 (1992).
7. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., Yamashita A., Waku K., Biochem. Biophys. Res. Commun., 215, 89-97 (1995).
8. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N. E., Schatz A. R., Gopher A., Almog S., Martin B. R., Compton D. R., Pertwee R. G., Griffin G., Bayewitch M., Barg J., Vogel Z., Biochem. Pharmacol., 50, 83-90 (1995).
9. Sugiura T., Kodaka T., Kondo S., Nakane S., Kondo H., Waku K., Ishima Y., Watanabe K., Yamamoto I., J. Biochem. (Tokyo), 122, 890-895 (1997).
10. Sugiura T., Kodaka T., Nakane S., Miyashita T., Kondo S., Suhara Y., Takayama H., Waku K., Seki C., Baba N., Ishima Y., J. Biol. Chem., 274, 2794-2801 (1999).
11. Sugiura T., Kondo S., Kishimoto S., Miyashita T., Nakane S., Kodaka T., Suhara Y., Takayama H., Waku K., J. Biol. Chem., 275, 605-612 (2000).
12. Gonsiorek W., Lunn C., Fan X., Narula S., Lundell D., Hipkin R. W., Mol. Pharmacol., 57, 1045-1050 (2000).
13. Hillard C. J., Prostaglandins Other Lipid Mediat., 61, 3-18 (2000).
14. Savinainen J. R., Jarvinen T., Laine K., Laitinen J. T., Br. J. Pharmacol., 134, 664-672 (2001).
15. Sugiura T., Kishimoto S., Oka S., Gokoh M., Prog. Lipid Res., 45, 405-446 (2006).
16. Stella N., Schweitzer P., Piomelli D., Nature (London), 388, 773-778 (1997).
17. Ameri A., Simmet T., Naunyn Schmiedebergs Arch. Pharmacol., 361, 265-272 (2000).
18. Guo J., Ikeda S. R., Mol. Pharmacol., 65, 665-674 (2004).
19. Kobayashi Y., Arai S., Waku K., Sugiura T., J. Biochem. (Tokyo), 129, 665-669 (2001).
20. Kishimoto S., Gokoh M., Oka S., Muramatsu M., Kajiwara T., Waku K., Sugiura T., J. Biol. Chem., 278, 24469-24475 (2003).
21. Kishimoto S., Kobayashi Y., Oka S., Gokoh M., Waku K., Sugiura T., J. Biochem. (Tokyo), 135, 517-524 (2004).
22. Gokoh M., Kishimoto S., Oka S., Mori M., Waku K., Ishima Y., Sugiura T., Biochem. J., 386, 583-589 (2005).
23. Oka S., Ikeda S., Kishimoto S., Gokoh M., Yanagimoto S., Waku K., Sugiura T., J. Leukoc. Biol., 76, 1002-1009 (2004).
24. Gokoh M., Kishimoto S., Oka S., Metani Y., Sugiura T., FEBS Lett., 579, 6473-6478 (2005).
25. Kishimoto S., Muramatsu M., Gokoh M., Oka S., Waku K., Sugiura T., J. Biochem. (Tokyo), 137, 217-223 (2005).
26. Jorda M. A., Verbakel S. E., Valk P. J., Vankan-Berkhoudt V., Maccarrone M., Finazzi-Agro A., Lowenberg B., Delwel R., Blood, 99, 2786-2793 (2002).
27. Walter L., Franklin A., Witting A., Wade C., Xie Y., Kunos G., Mackie K., Stella N., J. Neurosci., 23, 1398-1405 (2003).
28. Oka S., Yanagimoto S., Ikeda S., Gokoh M., Kishimoto S., Waku K., Ishima Y., Sugiura T., J. Biol. Chem., 280, 18488-18497 (2005).
29. Oka S., Wakui J., Ikeda S., Yanagimoto S., Kishimoto S., Gokoh M., Nasui M., Sugiura T., J. Immunol., 177, 8796-8805 (2006).
30. Lee M., Yang K. H., Kaminski N. E., J. Pharmacol. Exp. Ther., 275, 529-536 (1995).
31. Ouyang Y., Hwang S. G., Han S. H., Kaminski N. E., Mol. Pharmacol., 53, 676-683 (1998).
32. Gallily R., Breuer A., Mechoulam R., Eur. J. Pharmacol., 406, R5-R7 (2000).
33. Chang Y. H., Lee S. T., Lin W. W., J. Cell. Biochem., 81, 715-723 (2001).
34. Aderem A., Underhill D. M., Annu. Rev. Immunol., 17, 593-623 (1999).
35. Galiegue S., Mary S., Marchand J., Dussossoy D., Carriere D., Carayon P., Bouaboula M., Shire D., Le Fur G., Casellas P., Eur. J. Biochem., 232, 54-61 (1995).
36. Skaper S. D., Buriani A., Dal Toso R., Petrelli L., Romanello S., Facci L., Leon A., Proc. Natl. Acad. Sci. U.S.A., 93, 3984-3989 (1996).
37. Matias I., Pochard P., Orlando P., Salzet M., Pestel J., Di Marzo V., Eur. J. Biochem., 269, 3771-3778 (2002).
38. Klein T. W., Newton C., Friedman H., Immunol. Today, 19, 373-381 (1998).
39. Berdyshev E. V., Chem. Phys. Lipids, 108, 169-190 (2000).
40. Parolaro D., Massi P., Rubino T., Monti E., Prostaglandins Leukot. Essent. Fatty Acids, 66, 319-332 (2002).
41. Cabral G. A., "Biology of Marijuana," ed. by Onaivi E. S., Taylor & Francis, London, 2002, pp. 282-307.
42. Klein T. W., Larsen C. K., Lu L., Perkins I., Nong L., Friedman H., J. Leukoc. Biol., 74, 486-496 (2003).
43. Maestroni G. J., FASEB J., 18, 1914-1916 (2004).
44. Lopez-Cepero M., Friedman M., Klein T., Friedman H., J. Leukoc. Biol., 39, 679-686 (1986).
45. Friedman M., Cepero M. L., Klein T., Friedman H., Proc. Soc. Exp. Biol. Med., 182, 225-228 (1986).
46. Tang J. L., Lancz G., Specter S., Bullock H., Int. J. Immunopharmacol., 14, 253-262 (1992).
47. Bayewitch M., Rhee M. H., Avidor-Reiss T., Breuer A., Mechoulam R., J. Biol. Chem., 271, 9902-9905 (1996).
48. Toker A., Cantley L. C., Nature (London), 387, 673-676 (1997).
49. De Camilli P., Emr S. D., McPherson P. S., Novick P., Science, 271, 1533-1539 (1996).
50. Suchard S. J., Mansfield P. J., Boxer L. A., Shayman J. A., J. Immunol., 158, 4961-4967 (1997).
51. Garcia-Garcia E., Rosales R., Rosales C., J. Leukoc. Biol., 72, 107-114 (2002).
52. Karimi K., Lennartz M. R., Inflammation, 22, 67-82 (1998).
53. Garcia-Garcia E., Sanchez-Mejorada G., Rosales C., J. Leukoc. Biol., 70, 649-658 (2001).
54. Di Marzo V., Bisogno T., De Petrocellis L., Melck D., Orlando P., Wagner J. A., Kunos G., Eur. J. Biochem., 264, 258-267 (1999).
55. Berdyshev E. V., Schmid P. C., Krebsbach R. J., Schmid H. H. O., FASEB J., 15, 2171-2178 (2001).
56. Liu J., Batkai S., Pacher P., Harvey-White J., Wagner J. A., Cravatt B. F., Gao B., Kunos G., J. Biol. Chem., 278, 45034-45039 (2003).